Tamarack Advisers’s Exelixis EXEL Stock Holding History

Tamarack Advisers’s Portfolio EXEL Stock Details EXEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-200,000	Closed	-$4.53M	–	47
2022 Q1	$4.53M	Buy	+200,000	New	+$3.91M	2.15%	19

Other funds holding EXEL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Tamarack Advisers's EXEL Position: Q2 2022 in Review

Tamarack Advisers sold out of Exelixis (EXEL) in Q2 2022, closing a stake of 200,000 shares — an estimated $4.53M sold.

Tamarack Advisers first reported a position in EXEL in Q1 2022 and held it in 1 quarter. The position peaked at $4.53M in Q1 2022. 374 funds tracked by Wall St. Rank hold EXEL as of Q2 2022.

Tamarack Advisers reported no remaining Exelixis position as of Q2 2022 after selling out during the quarter.
Tamarack Advisers sold 200,000 Exelixis shares in Q2 2022, an estimated $4.53M.
Tamarack Advisers first reported a position in Exelixis in Q1 2022 and held it in 1 quarter.
Tamarack Advisers's Exelixis position peaked at $4.53M in Q1 2022.
374 funds tracked by Wall St. Rank held Exelixis as of Q2 2022.

Based on Tamarack Advisers's 13F filing for Q2 2022, filed 16 Aug 2022.